On presentation to the OSH VS 97.0; HR 57; BP 60/palp; RR 24; O2 sat 86% on RA (96% on NRB).
ABG 7.23/46/22.
Glucose was 558.
Urine ketones and urine gucose negative.
At the OSH, she received IVF, Hydrocortisone 100 mg IV once, Ertapenem 1 gm IV, had a KUB, CT chest and abdomen.
Bedside echo EF 55%, limited study, but no effusion noted or flow abnormalites detected.
CT chest showed PE.
Upon arrival to [**Hospital1 18**] ED initial VS HR 87; BP 108/70; O2 SAT 99% on 100 % NRB.
Glucose 280.
Blood cultures were drawn.
She had loose BM today after CT scan contrast at the OSH, but otherwise denies diarrhea, melena, or hematochezia.
CAD s/p STEMI [**11-16**] with 2VD s/p DES in LAD, POBA D1 with BMS to mid D1.
GVHD: skin, gut (now controlled), mouth,liver- left hand digit amps x4, chronic immune suppression cellcept, entocort, prednisone, rituxan (last [**2121-8-22**]) .
Neuro: alert and oriented x3, appropriate, moving all 4 extremities Skin: changes c/w GVH, hyperpigmentation of face, thick/tightened arm skin Rectal (per surgery note): trace guaiac +   Pertinent Results: [**2121-10-19**] 09:00PM URINE  RBC-[**12-1**]* WBC-0-2 BACTERIA-RARE YEAST-NONE EPI-0-2 [**2121-10-19**] 09:00PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-NEG GLUCOSE-100 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2121-10-19**] 09:00PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.041* [**2121-10-19**] 09:00PM   PT-15.8* PTT-150* INR(PT)-1.4* [**2121-10-19**] 09:00PM   PLT COUNT-316 [**2121-10-19**] 09:00PM   HYPOCHROM-NORMAL ANISOCYT-2+ POIKILOCY-2+ MACROCYT-2+ MICROCYT-2+ POLYCHROM-1+ SPHEROCYT-1+ SCHISTOCY-OCCASIONAL BURR-2+ STIPPLED-2+ TEARDROP-2+ PAPPENHEI-2+ ACANTHOCY-1+ [**2121-10-19**] 09:00PM   NEUTS-85* BANDS-1 LYMPHS-4* MONOS-8 EOS-0 BASOS-0 ATYPS-1* METAS-0 MYELOS-0 YOUNG-1* [**2121-10-19**] 09:00PM   WBC-11.2* RBC-3.20* HGB-10.8* HCT-31.7* MCV-99* MCH-33.8* MCHC-34.1 RDW-16.8* [**2121-10-19**] 09:00PM   CALCIUM-7.7* PHOSPHATE-3.7 MAGNESIUM-2.2 [**2121-10-19**] 09:00PM   CK-MB-4 [**2121-10-19**] 09:00PM   cTropnT-<0.01 [**2121-10-19**] 09:00PM   GLUCOSE-280* UREA N-19 CREAT-0.5 SODIUM-135 POTASSIUM-2.5* CHLORIDE-94* TOTAL CO2-27 ANION GAP-17 [**2121-10-19**] 09:34PM   LACTATE-3.9* [**2121-10-20**] 12:22AM   PT-14.9* PTT-150* INR(PT)-1.3* [**2121-10-20**] 12:23AM   LACTATE-2.0 K+-3.5 [**2121-10-20**] 12:23AM   COMMENTS-GREEN TOP [**2121-10-20**] 04:28AM   PT-13.6* PTT-53.6* INR(PT)-1.2* [**2121-10-20**] 04:28AM   PLT COUNT-303 [**2121-10-20**] 04:28AM   WBC-10.6 RBC-2.89* HGB-9.4* HCT-28.6* MCV-99* MCH-32.6* MCHC-32.9 RDW-16.7* [**2121-10-20**] 04:28AM   CALCIUM-7.9* PHOSPHATE-3.0 MAGNESIUM-2.2 [**2121-10-20**] 04:28AM   CK-MB-3 cTropnT-<0.01 proBNP-2673* [**2121-10-20**] 11:36PM   PT-14.2* PTT-150* INR(PT)-1.3* [**2121-10-20**] 04:29PM   PTT-150.0* [**2121-10-20**] 02:23PM   CK(CPK)-21* [**2121-10-20**] 02:23PM   CK-MB-3 cTropnT-<0.01 [**2121-10-20**] 02:17PM   PTT-150* [**2121-10-20**] 04:28AM   GLUCOSE-246* UREA N-13 CREAT-0.3* SODIUM-135 POTASSIUM-3.5 CHLORIDE-99 TOTAL CO2-29 ANION GAP-11  Brief Hospital Course: In brief the patient is a 39 year old woman with AML s/p related allo-PSCT, chronic GVHD, CAD s/p MI, DM who is admitted to ICU for close monitoring given bilateral PEs and hypotension on presentation.
The patient with bilateral PEs and R common femoral thrombus documented on the OSH CTA.
Upon transfer out of the [**Hospital Unit Name 153**], her heparin was transitioned to enoxaparin 1mg/kg [**Hospital1 **] for long-term anticoagulation.
Upon transfer out, her BP was stable and she was resumed on her home dose of beta blocker for rate control of her chronic sinus tachycardia.
EKG with ST depressions.
Her clopidogrel was held as above since she was 11 months out from stenting and since her new enoxaparin therapy would be further increasing her risk of bleeding.
- Had a PICC placed in the [**Hospital Unit Name 153**] (due to poor peripheral access) which was taken out prior to discharge.
Release 24HR(s)* Refills:*2* 3.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day): Do not take if your systolic blood pressure is less than 100, or your heart rate is less than 60 per minute.
Disp:*qs units* Refills:*2*   Discharge Disposition: Home With Service  Facility: All Care VNA of Greater [**Location (un) **]  Discharge Diagnosis: Primary diagnosis: bilateral pulmonary emboli  Secondary diagnoses: history of AML status-post bone marrow transplant; chronic cutaneous and GI GVHD; coronary artery disease; type 2 diabetes mellitus   Discharge Condition: stable   Discharge Instructions: You were admitted to the hospital with blood clots in both of your lungs.
Over the past few days, your blood pressure has been normal/borderline low.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) 1730**] [**Last Name (NamePattern4) 6175**], MD Phone:[**Telephone/Fax (1) 3237**] Date/Time:[**2121-11-6**] 12:30 Provider: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11755**], [**MD Number(3) 1240**]:[**Telephone/Fax (1) 3237**] Date/Time:[**2121-11-6**] 12:30
